TY - JOUR
T1 - Recognition and screening for Chagas disease in the USA
AU - Marcus, Rachel
AU - Henao-Martínez, Andrés F.
AU - Nolan, Melissa
AU - Livingston, Elizabeth
AU - Klotz, Stephen A.
AU - Gilman, Robert H.
AU - Miranda-Schaeubinger, Monica
AU - Meymandi, Sheba
N1 - Funding Information:
The initial idea for the manuscript was raised at an advisory board organized by Bayer where CD was discussed. This publication and its content are solely the responsibility of the authors. Editorial assistance was provided by Simpson Healthcare, which was funded by Bayer. Simpson Healthcare is committed to adhering to the prevailing standards for ‘Good Publication Practice’ (GPP3), as well as the criteria for authorship established by the International Committee of Medical Journal Editors.
Publisher Copyright:
© The Author(s), 2021.
PY - 2021
Y1 - 2021
N2 - Chagas disease (CD), caused by the protozoan Trypanosoma cruzi, is a public health concern, mainly among countries in South and Central America. However, despite the large number of immigrants from endemic countries living in the USA, awareness of CD is poor in the medical community, and therefore it is significantly underdiagnosed. To avoid the catastrophic cardiac complications of CD and to prevent maternal–fetal transmission, widespread educational programs highlighting the need for diagnosis are urgently needed.
AB - Chagas disease (CD), caused by the protozoan Trypanosoma cruzi, is a public health concern, mainly among countries in South and Central America. However, despite the large number of immigrants from endemic countries living in the USA, awareness of CD is poor in the medical community, and therefore it is significantly underdiagnosed. To avoid the catastrophic cardiac complications of CD and to prevent maternal–fetal transmission, widespread educational programs highlighting the need for diagnosis are urgently needed.
KW - Chagas disease
KW - Trypanosoma cruzi
KW - USA
KW - congenital Chagas
KW - screening
UR - http://www.scopus.com/inward/record.url?scp=85115632207&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85115632207&partnerID=8YFLogxK
U2 - 10.1177/20499361211046086
DO - 10.1177/20499361211046086
M3 - Review article
C2 - 34589212
AN - SCOPUS:85115632207
SN - 2049-9361
VL - 8
JO - Therapeutic Advances in Infectious Disease
JF - Therapeutic Advances in Infectious Disease
ER -